Theracryf Plc (FRA:8EV)

Theracryf Statistics

Total Valuation

Theracryf has a market cap or net worth of EUR 4.60 million. The enterprise value is -77,032.

Market Cap	4.60M
Enterprise Value	-77,032

Important Dates

The next estimated earnings date is Wednesday, December 3, 2025.

Earnings Date	Dec 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	2.13B
Shares Outstanding	n/a
Shares Change (YoY)	+95.83%
Shares Change (QoQ)	+53.91%
Owned by Insiders (%)	29.00%
Owned by Institutions (%)	56.61%
Float	1.25B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.65
P/TBV Ratio	1.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.03
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11

Current Ratio	3.11
Quick Ratio	3.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.71% and return on invested capital (ROIC) is -31.95%.

Return on Equity (ROE)	-46.71%
Return on Assets (ROA)	-24.83%
Return on Invested Capital (ROIC)	-31.95%
Return on Capital Employed (ROCE)	-35.59%
Revenue Per Employee	n/a
Profits Per Employee	-257,800
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-172,132
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	48.15
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-2.52M
Operating Income	-2.54M
Pretax Income	-2.49M
Net Income	-2.32M
EBITDA	-2.46M
EBIT	-2.54M
Earnings Per Share (EPS)	-0.00

Balance Sheet

The company has 4.92 million in cash and n/a in debt, giving a net cash position of 4.92 million.

Cash & Cash Equivalents	4.92M
Total Debt	n/a
Net Cash	4.92M
Net Cash Per Share	n/a
Equity (Book Value)	7.14M
Book Value Per Share	0.00
Working Capital	4.19M

Cash Flow

Operating Cash Flow	-2.83M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Theracryf does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-95.83%
Shareholder Yield	-95.83%
Earnings Yield	-50.41%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a